SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Cantor Fitzgerald Maintains Outperform on Harpoon Therapeutics, Raises Price Target to $24

Cantor Fitzgerald maintains Harpoon Therapeutics (NASDAQ:HARP) with a Outperform and raises the price target from $23 to $24.

Benzinga · -

Cantor Fitzgerald maintains Harpoon Therapeutics (NASDAQ:HARP) with a Outperform and raises the price target from $23 to $24.